Sam Collins

Sam Collins

Sam Collins is  InvestorPlace.com’s Chief Technical Analyst. He has more than four decades of experience in Wall Street firms.

In addition to providing fundamental and technical analysis for InvestorPlace.com, he provides FREE daily market commentary each trading day via the Daily Trader’s Alert. The Daily Trader’s Alert contains his Daily Market Outlook PLUS a Trade of the Day.

Sam served as a regular army captain serving in West Germany during the Berlin Wall Crisis before joining Merrill Lynch as a futures broker. Since then, he has been a financial adviser, branch manager, regional manager and certified portfolio manager with national and regional securities firms. While he retired in October 2009, during his career, he received recognition and numerous awards.

Sam used technical analysis as a timing and selection technique with portfolios that he managed. He developed a specific technical analysis technique and timing system called the Collins Bollinger Reversal (CBR) that has received national recognition, and he has appeared on local and national TV as a financial commentator.

As an equity specialist and technician, he uses technical analysis as a selection technique along with fundamental analysis. As a value buyer, his goal is to find companies with outstanding management, unique products and strong financials that have not yet been driven to unreasonable prices. His CBR system helps him to screen vast amounts of data for stocks that meet those standards.

Sam is also a member of the NASD Board of Arbitrators.

Recent Articles

Momentum Favors the Bears in the Short Term

The intermediate trend is still up, but the market currently lacks follow-through.

Trade of the Day: Buying Opportunity Emerging in EEM

A pullback within a new uptrend should provide a good entry point in iShares MSCI Emerging Markets Indx (ETF).

Market Pattern is Positive, Though Suspect

Traders should still exercise caution at this juncture.

Trade of the Day: Pounce on AMGN Stock on a Pullback

A decline to the 200-day moving average would provide an excellent entry point in Amgen, Inc.

Biotech May be Bargain Hunters’ Next Target

Buyers seem to be focused on only the most beaten-down sectors.